In This Section      
 

Hearts of ECMO

The Johns Hopkins Division of Cardiac Surgery is pleased to announce that New York City-based nonprofit organization Hearts of ECMO has generously committed $75,000 to fund an ECMO anti-coagulant study headed by Glenn Whitman, M.D., Professor, Division of Cardiac Surgery, and Director of Quality and the Cardiovascular Surgical Intensive Care Unit, and Dan Choi, M.D., Assistant Professor, Division of Cardiac Surgery, and Director of Temporary Mechanical Support. Hearts of ECMO funds promising ECMO research such as this study in an effort to improve outcomes and survival in these patients. 

Extracorporeal membrane oxygenation (ECMO) is a method of pumping and oxygenating a patient’s blood outside the body to allow the heart and lungs to rest after a traumatic event. It is also an important and improving technology in the field of transplantation, at times serving as a “bridge to transplant” or as a means to support patients if problems arise after a heart or lung transplantation.

Although ECMO can be lifesaving, close to 50% of patients have complications related to bleeding or clots. These complications in ECMO patients may rest on which blood thinners are used during treatment. Drs. Whitman and Choi will investigate this relationship in their upcoming clinical trial.

This kind of research is possible only when philanthropic collaborators join forces with the kind of top-notch investigators we are so fortunate to have at Johns Hopkins. These are the efforts that make us one of the best hospitals in the country, year in and year out.

Thank you to Hearts of ECMO for its generous support of this important ECMO research at Johns Hopkins!